Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.98
(-0.15%)
CNY 12.98
(-0.15%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 20.36 Billion CNY | 26.43% |
| 2022 | 16.1 Billion CNY | 7.39% |
| 2021 | 15 Billion CNY | 25.93% |
| 2020 | 11.91 Billion CNY | 19.24% |
| 2019 | 9.99 Billion CNY | 24.74% |
| 2018 | 8 Billion CNY | 34.31% |
| 2017 | 5.96 Billion CNY | 49.06% |
| 2016 | 4 Billion CNY | 26.37% |
| 2015 | 3.16 Billion CNY | 31.79% |
| 2014 | 2.4 Billion CNY | 21.01% |
| 2013 | 1.98 Billion CNY | 21.02% |
| 2012 | 1.64 Billion CNY | 25.14% |
| 2011 | 1.31 Billion CNY | 51.54% |
| 2010 | 864.87 Million CNY | 42.61% |
| 2009 | 606.45 Million CNY | 38.11% |
| 2008 | 439.12 Million CNY | 39.45% |
| 2007 | 314.9 Million CNY | 64.71% |
| 2006 | 191.18 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.19 Billion CNY | 20.28% |
| 2024 Q2 | 5.33 Billion CNY | 2.68% |
| 2024 Q3 | 5.75 Billion CNY | 7.89% |
| 2023 FY | 20.36 Billion CNY | 26.43% |
| 2023 Q3 | 5.79 Billion CNY | 10.78% |
| 2023 Q4 | 4.31 Billion CNY | -25.46% |
| 2023 Q2 | 5.23 Billion CNY | 4.2% |
| 2023 Q1 | 5.02 Billion CNY | 64.16% |
| 2022 Q3 | 4.94 Billion CNY | 25.53% |
| 2022 FY | 16.1 Billion CNY | 7.39% |
| 2022 Q1 | 4.16 Billion CNY | 22.44% |
| 2022 Q2 | 3.93 Billion CNY | -5.51% |
| 2022 Q4 | 3.05 Billion CNY | -38.14% |
| 2021 Q3 | 4.24 Billion CNY | 10.73% |
| 2021 Q2 | 3.83 Billion CNY | 9.27% |
| 2021 Q1 | 3.51 Billion CNY | 4.91% |
| 2021 FY | 15 Billion CNY | 25.93% |
| 2021 Q4 | 3.4 Billion CNY | -19.86% |
| 2020 Q2 | 2.52 Billion CNY | 53.66% |
| 2020 Q3 | 4.4 Billion CNY | 74.5% |
| 2020 Q4 | 3.34 Billion CNY | -23.96% |
| 2020 FY | 11.91 Billion CNY | 19.24% |
| 2020 Q1 | 1.64 Billion CNY | -27.31% |
| 2019 Q3 | 2.98 Billion CNY | 19.11% |
| 2019 Q1 | 2.24 Billion CNY | 19.12% |
| 2019 FY | 9.99 Billion CNY | 24.74% |
| 2019 Q4 | 2.25 Billion CNY | -24.3% |
| 2019 Q2 | 2.5 Billion CNY | 11.58% |
| 2018 Q1 | 1.74 Billion CNY | 10.52% |
| 2018 Q3 | 2.34 Billion CNY | 15.31% |
| 2018 Q4 | 1.88 Billion CNY | -19.63% |
| 2018 FY | 8 Billion CNY | 34.31% |
| 2018 Q2 | 2.03 Billion CNY | 16.41% |
| 2017 Q3 | 1.79 Billion CNY | 28.71% |
| 2017 Q4 | 1.58 Billion CNY | -11.82% |
| 2017 FY | 5.96 Billion CNY | 49.06% |
| 2017 Q1 | 1.19 Billion CNY | 30.49% |
| 2017 Q2 | 1.39 Billion CNY | 16.3% |
| 2016 FY | 4 Billion CNY | 26.37% |
| 2016 Q1 | 915.09 Million CNY | 26.43% |
| 2016 Q2 | 1 Billion CNY | 9.78% |
| 2016 Q3 | 1.16 Billion CNY | 15.78% |
| 2016 Q4 | 917.63 Million CNY | -21.1% |
| 2015 Q4 | 723.76 Million CNY | -26.72% |
| 2015 Q3 | 987.7 Million CNY | 23.13% |
| 2015 Q2 | 802.14 Million CNY | 23.03% |
| 2015 Q1 | 651.96 Million CNY | 15.66% |
| 2015 FY | 3.16 Billion CNY | 31.79% |
| 2014 Q2 | 596.87 Million CNY | 14.93% |
| 2014 FY | 2.4 Billion CNY | 21.01% |
| 2014 Q4 | 563.69 Million CNY | -21.94% |
| 2014 Q3 | 722.12 Million CNY | 20.98% |
| 2014 Q1 | 519.34 Million CNY | 8.8% |
| 2013 Q4 | 477.34 Million CNY | -21.28% |
| 2013 FY | 1.98 Billion CNY | 21.02% |
| 2013 Q1 | 413.37 Million CNY | -1.73% |
| 2013 Q2 | 487.89 Million CNY | 18.03% |
| 2013 Q3 | 606.35 Million CNY | 24.28% |
| 2012 Q1 | 354.55 Million CNY | 3.11% |
| 2012 Q4 | 420.65 Million CNY | -11.77% |
| 2012 Q3 | 476.78 Million CNY | 22.84% |
| 2012 Q2 | 388.14 Million CNY | 9.47% |
| 2012 FY | 1.64 Billion CNY | 25.14% |
| 2011 Q3 | 383.08 Million CNY | 18.58% |
| 2011 Q1 | 260.6 Million CNY | 10.72% |
| 2011 Q2 | 323.05 Million CNY | 23.97% |
| 2011 Q4 | 343.87 Million CNY | -10.24% |
| 2011 FY | 1.31 Billion CNY | 51.54% |
| 2010 FY | 864.87 Million CNY | 42.61% |
| 2010 Q2 | 194.84 Million CNY | 11.08% |
| 2010 Q1 | 175.41 Million CNY | 10.16% |
| 2010 Q3 | 259.24 Million CNY | 33.05% |
| 2010 Q4 | 235.36 Million CNY | -9.21% |
| 2009 Q1 | 126.16 Million CNY | 13.4% |
| 2009 FY | 606.45 Million CNY | 38.11% |
| 2009 Q4 | 159.23 Million CNY | -11.88% |
| 2009 Q3 | 180.7 Million CNY | 28.76% |
| 2009 Q2 | 140.34 Million CNY | 11.24% |
| 2008 FY | 439.12 Million CNY | 39.45% |
| 2008 Q3 | 132.31 Million CNY | 0.0% |
| 2008 Q4 | 111.25 Million CNY | -15.92% |
| 2007 FY | 314.9 Million CNY | 64.71% |
| 2006 FY | 191.18 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 80.11 Billion CNY | 74.579% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 10.88 Billion CNY | -87.077% |